CEP – Certificate of Suitability to the Monographs of the European Pharmacopoeia: Complete Guide 2026
Last Updated: January 15, 2026 | Reading Time: 12 mins
Filing for EU market authorization? If your drug product uses an active pharmaceutical ingredient, you’ll face this question: “CEP or ASMF?”
A CEP – Certificate of Suitability from EDQM can cut your EU approval timeline by months, reduce regulatory queries, and simplify lifecycle management. Yet many API manufacturers still choose ASMF by default, not knowing CEP advantages.
This guide covers everything QA, RA, and Business Development teams need: CEP process, CEP 2.0 updates, inspections, CEP vs DMF/ASMF, and strategic decisions for 2026.
What is a CEP Certificate?
A Certificate of Suitability to the monographs of the European Pharmacopoeia, commonly called CEP, is issued by the European Directorate for the Quality of Medicines & HealthCare – EDQM.
In simple terms: EDQM assesses your drug substance manufacturing process and quality control. If satisfied, they certify that your API’s quality is suitably controlled by the relevant Ph. Eur. monograph, plus any additional tests or specifications listed on the CEP.
Key Facts About CEP:
- Issued by: EDQM, Council of Europe, Strasbourg
- Valid in: 39 European Pharmacopoeia member states + UK, Australia, Canada, Singapore, others
- Validity: 5 years, renewable
- Scope: Drug substances with Ph. Eur. monograph + TSE for excipients
- Legal basis: EU Directive 2001/83/EC, Article 7
CEP vs ASMF vs DMF: Which Should You Choose?
| Parameter | CEP | ASMF – Active Substance Master File | US DMF |
|---|---|---|---|
| Authority | EDQM – Centralized | EMA/National Agencies – Decentralized | US FDA |
| Geography | 39 Ph. Eur. countries + others | EU/EEA only | USA only |
| Assessment | Once by EDQM | Repeated by each RMS/CMS | Once by FDA |
| Transparency | CEP shared with customer | Restricted + Applicant’s Part | LoA to customer |
| Updates | Centralized via EDQM | Submit to each agency | Annual report to FDA |
| Inspection | EDQM inspection possible | National GMP inspection | FDA inspection |
When to Choose CEP:
- Multiple EU customers: One CEP serves all, vs filing ASMF in 27 countries
- Generic products: Faster MA approval as CEP already proves Ph. Eur. compliance
- Tender markets: Many EU tenders mandate CEP
- Lifecycle ease: One variation to EDQM updates all customers
CEP 2.0: What Changed in the New Format?
EDQM launched CEP 2.0 to increase transparency and harmonize with ICH guidelines. All new CEPs and renewals now use this format.
Key CEP 2.0 Improvements:
- Clearer manufacturing site info: All sites listed with specific steps
- Impurity profile transparency: Specified, unspecified, total impurities clearly stated
- Re-test period + storage: Explicitly mentioned on CEP
- Specific conditions: Any additional tests beyond Ph. Eur. clearly listed
- QR code: Direct link to EDQM database for authenticity check
Impact: MAHs can assess CEP suitability faster. No more guessing if your process matches the CEP.
CEP Submission Process to EDQM: Step-by-Step
1. Pre-submission
Check Ph. Eur. monograph exists. Prepare Module 3.2.S in CTD format. Ensure GMP certificate available.
2. Dossier Submission
Submit via EDQM portal. Initial CEP fee: ~€4,500. Timeline: 120 days + clock stops.
3. Assessment
EDQM assessors review. Deficiency letter issued if needed. Typical 1-2 rounds.
4. Inspection – If Triggered
EDQM may inspect API site. Focus: Data integrity, cross-contamination, adherence to filed process.
5. CEP Granted
Valid 5 years. Listed on EDQM Certification Database. Customer can reference CEP in their MA dossier.
EDQM Inspections for CEP: What to Expect
Not all CEP applications trigger inspection. Risk-based triggers include:
- New manufacturing site with no EU GMP history
- Sterile APIs or high-potency substances
- Major process changes or complex synthesis
- Data integrity concerns from dossier
Inspection focus areas: Manufacturing process vs filed details, impurity fate/purge studies, stability data raw records, GMP compliance per EU GMP Part II.
Managing CEP Lifecycle: Renewals & Variations
| Change Type | EDQM Process | Timeline |
|---|---|---|
| Renewal | Submit 6 months before expiry | 60 days |
| Minor Variation | Type IA/IB notification | 30 days |
| Major Variation | Type II – assessment needed | 90 days |
| Admin Change | Site name/address | 30 days |
Key Rule: Any change to manufacturing process, specs, or site must be notified to EDQM before implementation if it impacts CEP.
Strategic Benefits of CEP for API Manufacturers
- Faster Customer Onboarding: Share CEP instead of full ASMF. MAH review time drops from 6 months to 2 weeks.
- Regulatory Leverage: CEP accepted by WHO PQ, TGA Australia, Health Canada. One dossier, global reach.
- Reduced Queries: EDQM pre-assessment means fewer questions during MA review.
- Tender Eligibility: EU hospital tenders often mandate CEP for APIs.
- Lifecycle Simplicity: One variation updates all customers vs 27 national filings.
Common CEP Challenges & How to Avoid Them
- Deficiency 1: Impurity control strategy weak
Fix: Provide fate & purge studies per ICH Q3A. Show spiking experiments. - Deficiency 2: Polymorph not addressed
Fix: If monograph has polymorph test, provide XRPD/IR data proving control. - Deficiency 3: Starting material definition
Fix: Justify starting material per ICH Q11. EDQM is strict on late-stage SMs. - Deficiency 4: GMP gaps
Fix: Ensure EU GMP Part II compliance. Mock inspection before EDQM visit.
FAQs on CEP Certificate
1. Is CEP mandatory for EU market?
No, but highly preferred. You can use ASMF. However, for Centralized Procedure and many DCP/MRP, CEP simplifies review.
2. Can I have both CEP and ASMF for same API?
Yes. Many firms maintain CEP for EU and US DMF for FDA. Processes must be identical.
3. How long does CEP approval take?
Average 8-12 months including clock stops. Fast track 6 months if no major deficiencies.
4. What if EDQM inspection fails?
CEP rejected or suspended. Existing customers notified. CAPA + re-inspection needed.
5. Does CEP cover micronization/sterilization sites?
Yes, if included in dossier. All sites performing critical steps must be listed on CEP.
Conclusion: Is CEP Right for Your API?
If you supply to 2+ EU customers, plan to enter tenders, or want faster MA approvals, CEP is a strategic asset. The upfront effort pays off in lifecycle ease and customer trust.
Next Steps:
- Check if Ph. Eur. monograph exists for your API
- Gap assessment: Your Module 3.2.S vs EDQM expectations
- Decide: CEP vs ASMF based on customer geography
The information provided on this page is for educational and informational purposes only. It is not intended to provide regulatory, legal, or compliance advice.
Pharmaceutical regulations including FDA 21 CFR, EU GMP Annexes, ICH Guidelines, EDQM, WHO, and CDSCO requirements are subject to frequent updates and interpretation by regulatory authorities.
Readers are responsible for ensuring compliance with current applicable laws and regulations in their jurisdiction. PharmaShare does not guarantee the accuracy, completeness, or currentness of this content.
This content does not create a consultant-client relationship. For product-specific regulatory strategy, dossier preparation, or inspection readiness, please consult qualified regulatory professionals or contact us directly.
About the Author
Mahummed Asif is a pharmaceutical QA professional with sound knowledge on GMP, Product Life Cycle Management, Regulatory filing, QMS, Product Complaint Management, Change control, risk management, and USFDA audit preparation.